UK Recommends GSK’s Long-Acting HIV Prevention Shot for NHS Use
The UK’s health watchdog, NICE, has approved ViiV Healthcare’s HIV prevention injection, Apretude, paving the way for its rollout on the National Health Service (NHS) in England and Wales. Apretude, developed by GSK’s ViiV Healthcare unit, is designed for pre-exposure prophylaxis (PrEP) — a treatment that prevents HIV infection in people at high risk. Unlike…